News and Insights

Print this page

Search News & Insights

Matheson advises Abtran in relation to the investment by Carlyle Cardinal Ireland

AUTHOR(S): Patrick Spicer, Madeline McDonnell
DATE: 27.11.2015

Matheson advised Abtran, one of Ireland’s largest providers of customer and business process management services, on the investment in Abtran by Carlyle Cardinal Ireland, the private equity fund. 
The transaction, which was announced on 23 November 2015, is one of the largest investments by Carlyle Cardinal Ireland in an Irish company to date. Abtran’s existing management team  will continue in their leadership roles and are investing further as shareholders in the business.

The Matheson team advising Abtran included corporate partners Patrick Spicer and Alan Chiswick and corporate senior associates Madeline McDonnell and Brian McCloskey. This transaction further illustrates Matheson’s track record of advising on high profile international transactions. Significant recent mandates also include advising Allergan Pharmaceuticals on its $66 billion merger with Actavis, Willis on its $18 billion merger with Towers Watson and Dyax on its US$5.9 billion sale to UK listed pharmaceutical company Shire.


About cookies on our website

Following a revised EU directive on website cookies, each company based, or doing business, in the EU is required to notify users about the cookies used on their website.

Our site uses cookies to improve your experience of certain areas of the site and to allow the use of specific functionality like social media page sharing. You may delete and block all cookies from this site, but as a result parts of the site may not work as intended.

To find out more about what cookies are, which cookies we use on this website and how to delete and block cookies, please see our Which cookies we use page.

Click on the button below to accept the use of cookies on this website (this will prevent the dialogue box from appearing on future visits)